Company profile: NEC OncoImmunity
1.1 - Company Overview
Company description
- Provider of AI-driven biotech solutions offering proprietary machine-learning software to predict bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. Products include NEC Immune Profiler, AI-driven neoantigen prediction for personalized cancer vaccines and cell therapies, and AI-based vaccine design for broadly protective vaccines against diverse viral species.
Products and services
- AI-driven Neoantigen Prediction: Proprietary AI technology that predicts immunogenic neoantigens for personalized cancer vaccines and cell therapies, focusing on bona fide antigen identification for individualized treatments
- AI-driven Vaccine Design: Computational platform that utilizes AI to design vaccines for infectious diseases, identifying optimal antigens to architect broadly protective vaccines against diverse viral species
- NEC Immune Profiler: Modular AI engine predicting neoantigens for personalized cancer immunotherapy by integrating HLA binding, antigen processing, and presentation modules to model immune recognition
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NEC OncoImmunity
Protein Forest
HQ: United States
Website
- Description: Provider of instruments, consumables, and software for protein separation and bioanalysis, serving scientists in the United States and internationally. Offers the digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein Forest company profile →
Enveda Biosciences
HQ: United States
Website
- Description: Provider of a drug discovery platform using machine learning, metabolomics, robotics, and the MS2Mol AI to index nature’s chemical space and predict structures from mass spectrometry, rapidly identifying small molecules; harnesses nature’s chemical diversity to deliver new medicines for complex diseases, novel modalities (protein degradation, stabilization, covalent inhibition), novel targets, and a pipeline in pain, dermatology, immunology, inflammation, and neuroinflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enveda Biosciences company profile →
ClinOne
HQ: United States
Website
- Description: Provider of clinical trial management solutions delivering web and mobile access to mission-critical trial details to improve enrollment, retention, site compliance, and patient experience. Offerings include Consent Management, Patient Engagement Portal, Site Hub, Sponsor & Monitor Hub (awareness, site selection, DEI data), Trial Awareness, and TeleVisit for remote video visits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinOne company profile →
Zageno
HQ: United States
Website
- Description: Provider of an enterprise marketplace connecting e-commerce to life science, offering an online platform to compare and procure lab supplies from various brands, procurement solutions including invoice consolidation and streamlined vendor setup, and a product selection and ordering platform with detailed information, pricing, and availability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zageno company profile →
Clarivate
HQ: United States
Website
- Description: Provider of trusted insights, analytics, data, workflow solutions, and deep domain expertise that help innovators discover, protect, and commercialize ideas faster. Offers real-world healthcare data, formulary tools, patient identification and assistance, and consulting in commercial strategy, evidence/value/access, and technology, including systems integration, data informatics, and custom solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clarivate company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NEC OncoImmunity
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NEC OncoImmunity
2.2 - Growth funds investing in similar companies to NEC OncoImmunity
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NEC OncoImmunity
4.2 - Public trading comparable groups for NEC OncoImmunity
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →